vimarsana.com

R Loch Macdonald News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Acasti Announces First Quarter 2024 Financial Results and Business Highlights

New leadership team singularly focused on executing GTX-104 strategyAnnounced alignment with the U.S. Food and Drug Administration (FDA) for Pivot.

United statesR loch macdonaldPrashant kohliAlejandroa rabinsteinW taylor kimberlyMike moyerSherryhy chouSamresh kumarNeurocritical care societyPhd vp program managementDrug administrationSecurities exchangeCompany classBoard of directors the companyExchange commissionAcasti pharma inc

ACASTI PHARMA INC : Change in Directors or Principal Officers, Other Events (form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 8, 2023, the Company appointed Dr.. | May 11, 2023

United statesUniversity of illinoisUnited kingdomBritish columbiaCarrie dandreaGeorge kottayilR loch macdonaldPierre lemieuxBrian fordPrashant kohliSamresh kumarCommunity health partnersGrace therapeutics incRutgers universityDivision of neurosurgeryProgram management

Acasti Successfully Submits Pivotal GTX-104 Phase 3 Safety Study Protocol with FDA and Implements Strategic Realignment Plan That Extends Projected Cash Runway Through Calendar Q2 2025

Company successfully submits GTX-104 Pivotal Phase 3 protocol IND amendment to the FDA with expectation for first patient dosed in calendar Q4 2023 Strategic realignment prioritizes GTX-104 and. | May 8, 2023

United statesRobert blumVimal kavuruR loch macdonaldPrashant kohliFletcher spaghtSamresh kumarCarrie dandreaVp program managementExchange commissionCompany nasdaqAcasti pharma incSecurities exchangeLytham partnersNew drug applicationAcasti pharma

vimarsana © 2020. All Rights Reserved.